UnknownNCT06268561

Ozurdex Endophtamitis Cohort, Prognostic Assessment at 12 Months

Studying Endophthalmitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Principal Investigator
Thibaud GARCIN, MD PhD
CHU SAINT-ETIENNE
Intervention
Visual acuity analysis(other)
Enrollment
8 enrolled
Eligibility
All sexes
Timeline
2023 – 2024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06268561 on ClinicalTrials.gov

Other trials for Endophthalmitis

Additional recruiting or active studies for the same condition.

See all trials for Endophthalmitis →

← Back to all trials